Palatin Technologies (NYSE:PTN) Price Target Raised to $70.00 at HC Wainwright

Palatin Technologies (NYSE:PTNGet Rating) had its price target raised by HC Wainwright to $70.00 in a report published on Friday, Stock Target Advisor reports. The firm currently has a buy rating on the stock.

Separately, StockNews.com assumed coverage on Palatin Technologies in a research report on Friday, September 2nd. They set a hold rating on the stock.

Palatin Technologies Trading Up 7.4 %

Palatin Technologies stock opened at $6.78 on Friday. The company has a current ratio of 3.53, a quick ratio of 3.44 and a debt-to-equity ratio of 0.01. Palatin Technologies has a 12 month low of $4.00 and a 12 month high of $24.00. The stock’s 50 day simple moving average is $1.05 and its two-hundred day simple moving average is $0.61. The firm has a market cap of $62.84 million, a PE ratio of -1.70 and a beta of 1.12.

Palatin Technologies Company Profile

(Get Rating)

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.

Further Reading

Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.